News and Announcements
Renewed investor confidence in Medical Devices sector according to PwC’s BioForum report
- Published November 08, 2013 11:37AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
By Sara Foale, PwC | Communications Manager
The Ex- major Medical Devices sector has emerged as the stand-out performer in this edition of BioForum – seeing 67 per cent growth in the last year and up 14.1 per cent for the quarter – suggesting renewed investor confidence in this previously volatile sector.
This is the key finding of PwC’s 45th edition of BioForum – a report on the listed Australian pharmaceutical, biotechnology and medical devices markets and the broader Life Sciences industry.
In other Q4, FY13 results:
– Life Sciences Index up 7 per cent
– Nasdaq Biotech up 20.7 per cent
– Nasdaq Composite up 10.8 per cent
– Life Sciences Index ex Majors up 15.4 per cent
– ASX All Ordinaries up 9.3 per cent
For more information please download the document below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
